CVRx (CVRX) Cash from Financing Activities (2020 - 2026)

CVRx's (CVRX) quarterly Cash from Financing Activities came in at $8.9 million in Q1 2026, down 7.62% year-on-year from $9.6 million in Q1 2025, and up 2066.34% quarter-over-quarter from $410000.0 in Q4 2025.

CVRx (CVRX) Cash from Financing Activities (2020 - 2026) Analysis & Trends

CVRx's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $8.9 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 7.62% year-over-year to $8.9 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a 84.74% decrease from a year earlier, with the FY2025 full-year figure at $10.5 million, down 81.17% from the prior year.
  • Cash from Financing Activities improved to $8.9 million in Q1 2026 per CVRX's latest filing, from $410000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $40.2 million in Q3 2024 and bottomed at $7000.0 in Q3 2022.
  • The 5-year median for Cash from Financing Activities is $473000.0 (2023), against an average of $6.3 million.
  • Across the five-year window, Cash from Financing Activities tumbled 99.99% in 2022 and jumped 15666.67% in 2023, its largest moves.
  • Year by year, Cash from Financing Activities stood at $7.1 million in 2022, then soared by 118.91% to $15.6 million in 2023, then retreated by 11.21% to $13.8 million in 2024, then plunged by 97.04% to $410000.0 in 2025, then surged by 2066.34% to $8.9 million in 2026.
  • Per Business Quant, the three latest CVRX Cash from Financing Activities figures stand at $8.9 million (Q1 2026), $410000.0 (Q4 2025), and $103000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 CVRx 128.88 Mn 56.58 Mn 12.88 Mn 8.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.88 Mn
Mar 31, 2026 8.88 Mn
Dec 31, 2025 410,000.00
Dec 31, 2025 410,000.00
Sep 30, 2025 103,000.00
Sep 30, 2025 103,000.00
Jun 30, 2025 392,000.00
Jun 30, 2025 392,000.00
Mar 31, 2025 9.62 Mn
Mar 31, 2025 9.62 Mn
Dec 31, 2024 13.83 Mn
Dec 31, 2024 13.83 Mn
Sep 30, 2024 40.20 Mn
Sep 30, 2024 40.20 Mn
Jun 30, 2024 472,000.00
Jun 30, 2024 472,000.00
Mar 31, 2024 1.36 Mn
Mar 31, 2024 1.36 Mn
Dec 31, 2023 15.58 Mn
Dec 31, 2023 15.58 Mn